Program Description
This engaging activity will feature expert insight into the most frequently encountered questions and concerns from pharmacists on the front lines of the COVID-19 pandemic. Pharmacists will learn valuable strategies to engage patients in clinical decision making regarding their health, with considerations focusing on COVID-19 treatment and reducing the burden of disease. This activity will feature a question-and-answer format, with the expert faculty offering insight and guidance on the latest information on COVID-19.
Target audience: Pharmacists
Type of activity: Application
Release date: February 28, 2022
Expiration date: February 28, 2023
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Determine common concerns from pharmacists regarding treatment initiation for patients with COVID-19
- Expose challenges with treatment of COVID-19 and preventing complications including the impact of new variants
- Differentiate evolving information about the safety and efficacy of available or investigational treatments for COVID-19
Christopher M. Bland, PharmD, FCCP, FIDSA, BCPS
Clinical Professor
Department of Clinical and Administrative Pharmacy
University of Georgia College of Pharmacy
Savannah, Georgia

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-22-059-H01-P. The activity is available for CE credit through February 28, 2023.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the webinar in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Christopher M. Bland, PharmD, FCCP, FIDSA, BCPS
Pharmacy Times Continuing Education™ Planning Staff: Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Dipti Desai, PharmD, CHCP; Liza Patel, PharmD, RPh; Liz Rauh; Susan Pordon; Brianna Winters; and Chloe Taccetta
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Medical reviewer James S. Lewis II, PharmD, FIDSA, has the following relevant financial relationship with a commercial interest to disclose:
Consultant: Merck
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
